Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Acute exacerbation of chronic bronchitis: Identifying patients who will benefit from antibiotic therapy

  • Antonio Anzueto

Producción científica: Article › revisión exhaustiva

Resumen

The role of bacterial infection and the use of antibiotics in acute exacerbation of chronic bronchitis are controversial. High-risk patients in whom the cost of clinical treatment failure is high and in whom antibiotics may be expected to produce a favorable outcome can be identified by simple clinical criteria. Stratification of patients according to disease severity will not only aid clinical management but will also allow more relevant information to be derived from future clinical studies. When selecting an antibiotic for treatment of an infectious episode, one must consider underlying patient co-morbidities, likely pathogens, local patterns of antibiotic resistance, and individual antibiotic properties. The choice of agents has greatly expanded, and newer antibiotics, such as the quinolones and macrolides, offer several therapeutic advantages over traditional compounds. These agents are recommended as a first-line choice in high-risk patients in whom therapeutic failure can have severe personal and economic consequences.

Idioma originalEnglish (US)
Páginas (desde-hasta)27-33
Número de páginas7
PublicaciónInfections in Medicine
Volumen16
N.ºSUPPL. F
EstadoPublished - oct 1999

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Huella

Profundice en los temas de investigación de 'Acute exacerbation of chronic bronchitis: Identifying patients who will benefit from antibiotic therapy'. En conjunto forman una huella única.

Citar esto